A Model for Highly Fluctuating Spatio-Temporal Infection Data, with Applications to the COVID EpidemicCOVID 전염병에 대한 적용과 함께 변동이 심한 시공간 감염 데이터에 대한 모델Article Published on 2022-05-302022-09-11 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 변종, [키워드] adaptive adopted Alpha variant alternation application autoregressive case study coefficient COVID Endemic endemicity England Epidemic expected feature Fluctuating followed by implication Infection infection level infection levels London Metrics Model Poisson model regime-switching short term spatio-temporal spillover Spread the epidemic transformations [DOI] 10.3390/ijerph19116669 PMC 바로가기 [Article Type] Article
Application of genetic algorithm combined with improved SEIR model in predicting the epidemic trend of COVID-19, China Research Published on 2022-05-262022-10-05 Journal: Scientific Reports [Category] 치료기술, 치료법, [키워드] adverse effect Algorithm application caused China COVID-19 COVID-19 epidemic disease Epidemic evaluate Genetic Guidance implementation Incubation period Infectious disease measure Measures outbreak parameter parameters predict SEIR the epidemic [DOI] 10.1038/s41598-022-12958-z [Article Type] Research
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study도시 이란 인구에서 SARS-CoV-2 항체의 혈청 유병률: 두 번째 대규모 인구 기반 단면 연구의 결과Article Published on 2022-05-232022-09-12 Journal: BMC Public Health [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI adjusted Anosmia arthralgia asked Asymptomatic chest pain chills conducted cough COVID-19 COVID-19 infection COVID-19-related symptoms cross-sectional diarrhea Dyspnea ELISA kits Fever First wave General population headache Health healthcare highest IgM antibody individual infected individual infected individuals Infection Iran lowest myalgia National participant Presence Randomly Registered SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2-specific IgG seropositive individual Seroprevalence Serosurvey sore throat Symptom Tabriz the disease the epidemic the SARS-CoV-2 weakness Weighting [DOI] 10.1186/s12889-022-13464-7 PMC 바로가기 [Article Type] Article
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-191차 진료 또는 병원 외래 환자 환경에 있는 환자가 COVID-19에 감염되었는지 확인하기 위한 징후 및 증상Review Published on 2022-05-202022-09-11 Journal: The Cochrane database of systematic reviews [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] 95% CI absence Abstract Accuracy addition Adults age Ageusia Analysis Anosmia applicability artificial intelligence assessment assessments Bern Chain Reaction characteristic checked children clinically clinically suspected clinics Cohort Combination combinations condition Consequences Contact Control coryza cough COVID-19 COVID-19 disease COVID-19 illness COVID-19 pneumonia COVID-19 testing criteria criterion Data collection database dependent on detection rate determine determined by diagnostic Diagnostic accuracy diagnostic test diagnostic tests diagnostic value disease Dyspnoea eligibility eligible emergency department enrolled Evidence excluded fatigue Fever FIVE Gender Health Service Health services help heterogeneity high risk hospital identify increase individual individual symptom Infection Infectious disease information initial investigated life-threatening likelihood ratio Local loss of sense of smell majority mechanism median Meta-analysis Mild Mild COVID-19 disease moderate MOST multivariable no symptom no symptoms nursing homes Older olfactory on children Outpatient outpatients overlapping pair parameter participant Participants Patient PCR Pneumonia polymerase chain polymerase chain reaction positive Presence presenting primary care Probability Prognosis Prospective Study QUADAS-2 random-effect reached receiver operating characteristic recruited reference standard Reference standards referred to reported Repository resolved Result reverse transcription reverse transcription polymerase chain reaction risk of bia ROC RT-PCR Sample size SARS-COV-2 infection selected Selection sense sense of smell sensitivity Sensitivity and specificity SIGN Signs and symptoms sore sore throat specific symptom Specificities specificity Support Symptom Symptoms Taste the disease the epidemic Travel treated University of Bern upper respiratory symptom upper respiratory symptoms were measured with COVID-19 [DOI] 10.1002/14651858.CD013665.pub3 PMC 바로가기 [Article Type] Review
Machine learning-based optimization of pre-symptomatic COVID-19 detection through smartwatch Research Published on 2022-05-122022-10-05 Journal: Scientific Reports [Category] 바이오마커, 변종, 치료기술, [키워드] accelerate asymptomatic infection average collected COVID-19 COVID-19 infection False positives heart identify Infection machine Mutation NAT no symptom Patient physiological pre-symptomatic Rate reported resting Spread spread of COVID-19 subject’ Symptoms the epidemic vector [DOI] 10.1038/s41598-022-11329-y [Article Type] Research
Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaquesArticle Published on 2022-05-102022-10-05 Journal: Molecular therapy : the journal of the American So [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] AAV acute respiratory syndrome adeno-associated virus approval breakthrough infections consequence Coronavirus-2 COVID-19 COVID-19 pandemic COVID-19 vaccine cynomolgus macaque dose Durability Effective vaccines Efficacy elicit genetic vaccine greater Health Immunity IMPROVE injection lack low-dose macaque maintain mice Neutralizing antibody response non-human primate non-human primates other variant platform preventative vaccine PROTECT reduced Safe SARS-CoV-2 shown single dose the epidemic Vaccine vaccine antigen vaccine candidate variants variants of concern viral challenge virus [DOI] 10.1016/j.ymthe.2022.05.007 [Article Type] Article
Dynamic of anti-spike receptor binding domain (RBD) levels and short-term adverse events following a heterologous booster dose of BNT162b2 after two doses of CoronaVac in Thai health care workers태국 의료 종사자에게 코로나백 2회 투여 후 BNT162b2의 이종 부스터 투여 후 항스파이크 수용체 결합 도메인(RBD) 수준 및 단기 부작용의 역학Article Published on 2022-05-092022-09-11 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] (Abbott) Abbott Administered Adverse adverse event anti-RBD anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody Anti-spike Anti-spike receptor binding domain antibody Architect average being BNT162b2 booster booster dose booster vaccination completion conducted CoronaVac COVID COVID mRNA vaccine COVID-19 COVID-19 vaccine dose dynamic evaluate female HCW HCWs Health care Health care worker Heterologous hospital humoral immune response IgG antibodies IgG antibody immunogenicity log median median age mRNA of BNT162b2 participant Participants promoted RBD receive Receptor binding Receptor binding domain resulting SARS-CoV-2 IgG Serious Adverse Events severe adverse effect Side effect significantly the epidemic variants was determined were assessed [DOI] 10.1016/j.vaccine.2022.04.020 PMC 바로가기 [Article Type] Article
The first three waves of the Covid-19 pandemic hint at a limited genetic repertoire for SARS-CoV-2Covid-19 전염병의 처음 세 가지 물결은 SARS-CoV-2에 대한 제한된 유전 레퍼토리를 암시합니다Article Published on 2022-05-062022-09-11 Journal: FEMS microbiology reviews [Category] COVID19(2023년), SARS, 변종, [키워드] Alpha B.1.1.529 B.1.1.7 B.1.177 B.1.617.2 Delta Genetic genetic repertoire genomic hand homoplasies introduced janus Lineage Mutation mutation frequency nucleotide nucleotides observé omicron Omicron variant pandemic Pango lineages Recombination replaced REPLACED BY SARS-CoV-2 SARS-CoV-2 genome SARS-CoV-2 genome sequence SARS-CoV-2 genome sequences splitting the epidemic the SARS-CoV-2 genome variant variants variants of concern variants of concern (VOCs) viral replication virus VOCs [DOI] 10.1093/femsre/fuac003 PMC 바로가기 [Article Type] Article
Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2 Research Published on 2022-05-042022-10-05 Journal: Nature Communications [Category] COVID19(2023년), SARS, 바이오마커, 진단, [키워드] Bayesian clinical Coverage cross-sectional determine Elecsy equity FIVE greater hospital Immunity individual Infection infection risk infection with SARS-CoV-2 interval MONITOR Mortality pandemic Probability provide Roche San Francisco SARS-CoV-2 sera Spread tested the epidemic unique vaccination Vaccine while white [DOI] 10.1038/s41467-022-30051-x [Article Type] Research
Lessons drawn from China and South Korea for managing COVID-19 epidemic: Insights from a comparative modeling studyCOVID-19 전염병 관리를 위해 중국과 한국에서 얻은 교훈: 비교 모델링 연구의 통찰력Article Published on 2022-05-012022-09-11 Journal: ISA transactions [Category] COVID19(2023년), SARS, 치료기술, [키워드] 95% confidence interval Analysis approach basic reproduction number Characteristics China Comparative Comparative study conducted confirmed case COVID-19 COVID-19 epidemic cumulative detection rate disease transmission effective Effectiveness Epidemic Epidemics evaluate Guangdong identify initial insight key factor Korean lesson mainland Mainland china and south korea mathematical model Multi-source data. outbreak Public health intervention Reproduction number sensitivity analysis South South Korea Standard deviation the epidemic threshold [DOI] 10.1016/j.isatra.2021.12.004 PMC 바로가기 [Article Type] Article